Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Diagnostic tests company announces comarketing agreement with Cambrex Bio Science
October 27th, 2005
Quidel Corporation (QDEL) announced at the 27th Annual American Society of Bone and Mineral Research (ASBMR) conference that its specialty products group (SPG) has secured strategic comarketing agreements with Cambrex Bio Science Walkersville, Inc., based in Walkersville, Maryland, and Nordic Bioscience Diagnostics A/S, based in Herlev, Denmark. These partnerships will leverage Quidel's global capabilities to collaborate with osteoporosis research institutions for the development of new markers, which may benefit osteoporosis and post-menopausal patients. Quidel's 2-year partnership with Nordic Bioscience Diagnostics is a comarketing and sales...
Source: Women's Health Weekly (2005-10-27)
|
